Charles River FDA Collaboration With Labcorp Targets New Preclinical Methods for Abuse Potential Assessment
Charles River, Labcorp and the FDA have signed a Research Collaboration Agreement to develop sensitive preclinical tools that quantify and rank the abuse potential of new drugs, including abuse-deterrent formulations.
